Attitudes of healthcare workers and members of the public toward the COVID-19 vaccine: A cross-sectional survey.
COVID-19 vaccine
healthcare workers
information sources
knowledge
risk perception
trust
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
30 11 2022
30 11 2022
Historique:
pubmed:
1
11
2022
medline:
15
12
2022
entrez:
31
10
2022
Statut:
ppublish
Résumé
The COVID-19 pandemic has led to the rapid development and implementation of vaccines. However, uncertainty about their safety and effectiveness among some people has led to vaccine hesitancy. We conducted a cross-sectional survey in March 2021 among individuals from the general Israeli population and health-care workers (HCWs) to examine risk perception toward the COVID-19 vaccine, trust in health-care providers and information sources used for making health-related decisions. The study population included 739 respondents: 42.6% HCWs and 57.4% members of the public. Participants' perceived risk toward the vaccine was relatively low in both populations. Higher perceived benefit of the vaccine, higher perceived extent of knowledge that doctors have about the risk associated with the vaccine, higher perceived freedom to choose whether to get vaccinated and higher trust in health-care providers predicted lower perceived risk toward the vaccine. Individuals who showed greater health responsibility, those who usually get vaccinated against influenza and those who had greater objective knowledge on the COVID-19 vaccine demonstrated lower perceived risk. No statistically significant difference in trust level was found between HCWs and members of the public. Both populations regarded information from medical sources as their greatest influence on health-related decisions. The study points to the factors influencing the perceived risk toward the COVID-19 vaccine and emphasizes the unique status of HCWs having their own views and concerns about the vaccine as individual members. Policymakers should consider these factors when planning national vaccination campaigns.
Identifiants
pubmed: 36314896
doi: 10.1080/21645515.2022.2124782
pmc: PMC9746361
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2124782Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
BMC Public Health. 2015 Apr 26;15:424
pubmed: 25928741
Risk Anal. 2020 Nov;40(S1):2191-2206
pubmed: 32949022
Lancet Respir Med. 2022 Feb;10(2):e19
pubmed: 35030317
Science. 1987 Apr 17;236(4799):280-5
pubmed: 3563507
Health Promot Int. 2022 Jun 1;37(3):
pubmed: 35788306
Isr J Health Policy Res. 2021 Jan 26;10(1):6
pubmed: 33499905
Hum Vaccin Immunother. 2012 Sep;8(9):1272-82
pubmed: 22894959
Risk Anal. 2013 Jun;33(6):1049-65
pubmed: 23278120
Health Psychol. 2007 Mar;26(2):136-45
pubmed: 17385964
Postgrad Med J. 2023 Jun 15;99(1172):520-528
pubmed: 37319159
Vaccines (Basel). 2021 Aug 13;9(8):
pubmed: 34452026
Vaccine. 2012 May 28;30(25):3771-7
pubmed: 22445808
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Hum Vaccin Immunother. 2022 Nov 30;18(5):2074716
pubmed: 35714274
Risk Anal. 2001 Jun;21(3):457-65
pubmed: 11572426
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Front Psychol. 2020 Sep 04;11:2166
pubmed: 33013555
Occup Environ Med. 2012 Apr;69(4):230-5
pubmed: 22172951
Risk Anal. 2000 Jun;20(3):353-62
pubmed: 10949414
Am J Infect Control. 2015 Jul 1;43(7):669-75
pubmed: 25920703
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Risk Manag Healthc Policy. 2021 Jun 01;14:2253-2261
pubmed: 34104016
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
Psychiatry Res. 2015 May 30;227(1):27-31
pubmed: 25813776
Eur J Epidemiol. 2021 Jul;36(7):709-714
pubmed: 34037927
Risk Anal. 2021 Mar;41(3):480-490
pubmed: 31046144
Int J Public Health. 2021 May 14;66:636255
pubmed: 34744589
Ther Innov Regul Sci. 2018 Sep;52(5):629-640
pubmed: 29714546
Risk Anal. 1994 Dec;14(6):1101-8
pubmed: 7846319
Am J Infect Control. 2014 Aug;42(8):829-33
pubmed: 24939516
Risk Anal. 2021 May;41(5):787-800
pubmed: 33438218
EClinicalMedicine. 2020 Jun 24;24:100443
pubmed: 32766545
J Infect. 2009 Oct;59(4):252-8
pubmed: 19683347
Risk Anal. 2018 Mar;38(3):504-524
pubmed: 28675477
J Public Health Med. 2003 Jun;25(2):161-4
pubmed: 12848408
Front Public Health. 2015 Jan 13;2:289
pubmed: 25629026
Vaccines (Basel). 2022 Jun 15;10(6):
pubmed: 35746556
Risk Anal. 2022 Oct;42(10):2214-2230
pubmed: 34791678
Risk Anal. 2000 Oct;20(5):713-9
pubmed: 11110217
Risk Anal. 2000 Apr;20(2):195-203
pubmed: 10859780
Vaccine. 2015 Jun 4;33(24):2741-56
pubmed: 25936726
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
PLoS One. 2022 Feb 2;17(2):e0263351
pubmed: 35108313
Risk Anal. 2004 Oct;24(5):1289-99
pubmed: 15563295
Risk Anal. 2017 Nov;37(11):2150-2163
pubmed: 28314047
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Int J Environ Res Public Health. 2020 Apr 29;17(9):
pubmed: 32365710
BMC Public Health. 2021 Aug 18;21(1):1562
pubmed: 34404377
Lancet. 2017 Jun 24;389(10088):2503-2513
pubmed: 28495109